Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | NGR-TNF |
Synonyms | |
Therapy Description |
NGR-TNF is a vascular disrupting recombinant protein that forms from the fusion of the TNF-alpha N terminal domain and the peptide, CNGRCG, which specifically targets CD13 possibly resulting in the interruption of tumor growth (PMID: 23828516, PMID: 29490991). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NGR-TNF | NGR-TNF is a vascular disrupting recombinant protein that forms from the fusion of the TNF-alpha N terminal domain and the peptide, CNGRCG, which specifically targets CD13 possibly resulting in the interruption of tumor growth (PMID: 23828516, PMID: 29490991). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|